Last Posted: Mar 15, 2018
- High Blood Pressure & Kidney Disease
NIDDK - Impact of CYP2C19 polymorphism in prognosis of minor stroke or TIA patients with declined eGFR on dual antiplatelet therapy: CHANCE substudy.
Wu Yu, et al. The pharmacogenomics journal 2018 3 - Genetic risk score and risk of stage 3 chronic kidney disease.
Ma Jiantao et al. BMC nephrology 2017 Jan 18(1) 32 - National Chronic Kidney Disease Fact Sheet 2017
CDC, Mar 2018 - National Kidney Month
NIDDK, Mar 2018 - The Role of Lipoprotein(a) in Chronic Kidney Disease.
Hopewell Jemma C et al. Journal of lipid research 2018 Jan
.png)
No hay comentarios:
Publicar un comentario